生命科学资讯
生物技术与制药领域的最新动态
Ultragenyx在经历艰难的2025年后将裁员约130人
Ultragenyx to lay off about 130 employees after rough 2025
Icon公司披露内部会计调查后股价暴跌40%
Icon's stock drops 40% after disclosing internal accounting probe
艾伯维就肉毒杆菌素入选IRA谈判提起法律诉讼。
AbbVie sues over selection of Botox for IRA negotiations
制药业对FDA放宽处方药转非处方药计划表示反对。
Pharma pushes back on FDA plans to ease prescription-OTC drug switches
诺和诺德将扩建爱尔兰工厂以生产Wegovy口服药。
Novo Nordisk to expand Irish factory for Wegovy pill
卡西迪法案拟禁止药品行业关注的海关漏洞。
Cassidy bill seeks to ban a customs loophole on pharma's radar
赛诺菲新任CEO贝伦·加里霍面临挑战,遭遇冷淡反应。
Sanofi’s new CEO Belén Garijo gets frosty reception as challenges await
胰腺癌疗法获批;Seres公司裁员
A pancreatic cancer approval; Seres cuts staff
欧洲生物制药的未来,连欧洲人自己也不看好了。
Even Europeans don't see a future in Euro biopharma anymore
Terray宣称其AI模型在结合亲和力预测上超越Boltz-2。
Terray says its AI model beats Boltz-2 at binding affinity prediction
莱尔启动首个头对头CAR-T疗法试验
Lyell starts first head-to-head CAR-T therapy trial
BridgeBio侏儒症药物三期试验成功,再添晚期研发新胜利。
BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins
欧洲风投组建联盟以争取更多生物科技投资支持。
European VCs form coalition to get more support for biotech investing
赛诺菲CEO保罗·哈德森卸任,贝伦·加里霍将接任新首席执行官。
Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO
Hinge Health计划开发用于心理健康支持的AI工具
Hinge Health is looking to build AI tools for mental health support
FDA或考虑在更小范围使用Moderna流感疫苗
FDA may consider Moderna's flu vaccine in a narrower group
前阿斯利康高管在华被控非法交易
Former AstraZeneca senior staff charged with illegal trade in China
普拉萨德否决疫苗审查团队及办公室主管对Moderna流感疫苗的建议。
Prasad overruled vaccine review team, office director on Moderna flu shot
CEO离职后,CSL披露利润暴跌及11亿美元减值成本
After CEO departs, CSL details profit crash, $1.1B impairment costs